Please assess the completion status of the following clinical trial:

Trial Title: Pilot Investigation of Stem Cells in Stroke

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Males~* 60 years or over~* Unilateral ischemic stroke involving subcortical white matter or Basal Ganglia 6 months to 5 years before entry~* NIHSS score minimum 6 with hemiparesis (2 or more for motor arm and leg)~* Neurologically stable for 2 m~* modified Rankin score of 2-4~* Fit for general anesthesia, neurosurgery~* Capacity to consent~* Infarct at least 1cm diameter~Exclusion Criteria:~* Structural brain vascular lesions requiring surgery or increasing the risk of stereotaxic implantation~* Unstable medical conditions with expected survival \<12 months~* Any medical condition that would impair participation (eg progressive neurological disorders, mental illness)~* Major surgery within 30 days~* Previous allogeneic tissue transplant~* MMSE \< 24~* Epilepsy~* Coagulation disorders or anticoagulant treatment that cannot be interrupted~* Stimulants, botox, tamoxifen~* Contraindications to MRI

- Gender: MALE
- Minimum Age: 60 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- CTX0E03 DP (Type: EXPERIMENTAL): human neural stem cell product, once only injection, increasing doses

Based on this trial design, predict the completion outcome and termination type (if applicable).